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The advanced stages of many illnesses and their treatments are
often accompanied by intractable nausea, vomiting, or pain. Thou
sands of patients with cancer, AIDS, and other diseases report they
have obtained striking relief from these devastating symptoms by
smoking marijuana.1The alleviation of distress can be so striking
that some patients and their families have been willing to risk ajail
term to obtain or grow the marijuana.
Despite the desperation of these patients, within weeks after
voters in Arizona and California approved propositions allowing
physicians in their states to prescribe marijuana for medical indica
tions, federal officials, including the President, the secretary of
Health and Human Services, and the attorney general sprang into
action. At a news conference, Secretary Donna E. Shalala gave an
organ recital of the parts of the body that she asserted could be
harmed by marijuana and warned of evils of its spreading use.
Attorney General Janet Reno announced that physicians in any
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state who prescribed the drug could lose the privilege of writing
prescriptions, be excluded from Medicare and Medicaid reimburse
ment, and even be prosecuted for a federal crime. General Barry R.
McCaffrey, directory of the Office ofNational Drug Control Policy,
reiterated his agency’s position that marijuana is a dangerous drug
and implied that voters in Arizona and California had been duped
into voting for these propositions. He indicated that it is always
possible to study the effects of any drug, including marijuana, but
that the use of marijuana by seriously ill patients would require, at
the least, scientifically valid research.
I believe that a federal policy that prohibits physicians from
alleviating suffering by prescribing marijuana for seriously ill
patients is misguided, heavy-handed, and inhumane. Marijuana
may have long-term adverse effects and its use may presage serious
addictions, but neither long-term side effects nor addiction is a
relevant issue in such patients. It is also hypocritical to forbid
physicians to prescribe marijuana while permitting them to use
morphine and meperidine to relieve extreme dyspnea and pain.
With both these drugs the difference between the dose that relieves
symptoms and the dose that hastens death is very narrow; by
contrast, there is no risk of death from smoking marijuana. To
demand evidence of therapeutic efficacy is equally hypocritical.
The noxious sensations that patients experience are extremely
difficult to quantify in controlled experiments. What really counts
for a therapy with this kind of safety margin is whether a seriously
ill patient feels relief as a result of the intervention, not whether a
controlled trial “proves” its efficacy.
Paradoxically, dronabinol, a drug that contains one of the active
ingredients in marijuana (tetrahydrocannabinol), has been available
by prescription for more than a decade. But it
is difficult to titrate the therapeutic dose of this
drug, and it is not widely prescribed. By con
trast, smoking marijuana produces a rapid
increase in the blood level of the active ingre
dients and is thus more likely to be therapeu
tic. Needless to say, new drugs such as those
that inhibit the nausea associated with chemo
therapy may well be more beneficial than
smoking marijuana, but their comparative ef
ficacy has never been studied.
Whatever their reasons, federal officials are
out of step with the public. Dozens of states
have passed laws that ease restrictions on the
prescribing of marijuana by physicians, and
polls consistently show that the public favors
the use of marijuana for such purposes.1Fed
eral authorities should rescind their prohibi
tion of the medicinal use of marijuana for
seriously ill patients and allow physicians to
decide which patients to treat. The govern
ment should change marijuana’s status from
that of a Schedule 1 drug (considered to be
potentially addictive and with no current medi
cal use) to that of a Schedule 2 drug (poten
tially addictive but with some accepted medi
cal use) and regulate it accordingly. To ensure
its proper distribution and use, the govern
ment could declare itself the only agency
sanctioned to provide the marijuana. I believe
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that such a change in policy would have
no adverse effects. The argument that it
would be a signal to the young that “mari
juana is OK” is, I believe, specious.
This proposal is not new. IN 1986,
after years of legal wrangling, the Drug
Enforcement Administration (DEA) held
extensive hearings on the transfer of
marijuana to Schedule 2. In 1988, the
DEA’ s own administrative-law judge
concluded, “It would be unreasonable,
arbitrary, and capricious for DEA to con
tinue to stand between those sufferers
and the benefits of this substance in light
ofthe evidence in this record.” Nonethe
less, the DEA overruled the judge’s or
der to transfer marijuana to Schedule 2,
and in 1992 it issued a final rejection of
all requests for reclassification.
Some physicians will have the courage
to challenge the continued proscription
of marijuana for the sick. Eventually,
their actions will force the courts to adju
dicate between the right of those at death’s
door and the absolute power of bureau
crats whose decisions are based more on
reflexive ideology and political correct
ness than on compassion.
Editor’s Note:
The Doctor’s Dilemma
Compassion, as defined in the dictio
nary, is the feeling of “sorrow for the
distress of another; with the desire to
help.” Indeed, it is this feeling of com
passion that unifies us as physicians,
and that motivates us to continue to
practice the art ofmedicine day by day.
The understanding that medicine is
not strictly scientific intercourse, but an
art form as well, has permitted us as
physicians to use our bestjudgement in
the care ofpatients when faced with a
dilemma.
In recent years, governmental con
straints have posed a different type of
dilemma before our medical commu
nity—one with far-reaching horns ca
pable ofmortally wounding ournation’s
strong medical profession, and by ex
trapolation, our patients. Today’s two-
pronged conundrum is this: can we con
tinue to treat patients with compassion
and best judgement while still remain
ing in compliance with new law?
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Until there’s a cure,
there’s the American
Diabetes Association.
and suffering of the dying patient. I hope to
work toward an improvement in physician
skills in this area.
I was moved to write this after getting a
consult letter from you with Hemlock Soci
ety info inserted. I cannot support you on
this one, in fact I’ll fight you every inch of
the way.
I have always had the utmost re
spect for your causes and crusades. I
have followed and praised your work
for historic preservation and avoid
ance of sun radiation. I am, therefore,
saddened by your support and crusade
for physician assisted suicide.
Physicians and healers. Tradition
has banned assisted suicide since the
time of Hippocrates. Physician as
sisted suicide is a slippery slope, very
slippery. I fear what it will lead to. I
believe that we, the profession, can do
a much better job in relieving the pain
natologists, intensivists, etc.
These are the ones who interface with
the public and are intimately involved
with pulling or not “pulling the plug”
(also transplant surgeons).
I, and I’m sure other of similar stripe,
would be willing to serve.
John H. Houk MD
Walter K. T Shim MD
I noted with interest that in your
1/97 editorial of the HMJ the Blue/Black
Ribbon panel had an absence of physicians
who are on the front lines of decision mak
ing such as pediatric surgeons, trauma sur
geons, oncologists, oncologic surgeons, neo
